Ascendia is a speciality CDMO dedicated to developing enhanced formulations for poorly water-soluble molecules. Ascendia provides comprehensive services-analytical, preformulation, formulation development, and cGMP manufacture of clinical materials. Ascendia formulates products for injection, topical delivery, and for oral administration. Our formulation expertise includes nanoparticles, nano-emulsions, and amorphous solid dispersions.
Ascendia Pharmaceuticals
675 US Highway One, North Brunswick, NJ 08902
tel. 732.640.0058
INTERPHEX Booth #1567
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.